Taku Tsukamoto
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 08, 2025
The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.Hiroaki Nagata, Taku Tsukamoto, Tsutomu Kobayashi
|Dec 05, 2023
miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.Yuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano
|Oct 16, 2023
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.Yoko Katsuragawa-Taminishi, Shinsuke Mizutani, Yuka Kawaji-Kanayama
|Jan 06, 2022
Expression of activated B-cell gene signature is predictive of the outcome of follicular lymphoma.Taku Tsukamoto, Yuichi Tokuda, Masakazu Nakano
Pageof 1
